|Articles|August 29, 2019
High-touch services that enhance patient outcomes
Author(s)McKesson Life Sciences
In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.
Related Content
Trending on PharmExec
1
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
4
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
5